Loading clinical trials...
Loading clinical trials...
Prospective, Observational Safety Study of Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Treated With Rituximab
Conditions
Interventions
Rituximab
Locations
15
United States
Mayo Clinic Arizona
Scottsdale, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Mayo Clinic
Jacksonville, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
Johns Hopkins Asthma&Allergy
Baltimore, Maryland, United States
Mass. General Hospital
Boston, Massachusetts, United States
Start Date
June 20, 2012
Primary Completion Date
July 13, 2015
Completion Date
April 28, 2017
Last Updated
July 26, 2018
NCT03004326
NCT05979051
NCT06046222
NCT07343661
NCT05263934
NCT03557060
Lead Sponsor
Genentech, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions